23.12.2013 - Merck Serono, the biopharmaceuticals division of Germany's Merck KGaA, has signed a global license agreement with the Spanish National Research Center (CNIO) in Madrid on cancer...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)